Massimo, G.; Dyson, N.; Olotu, F.; Khambata, R.S.; Ahluwalia, A.
Potential Opportunities for Pharmacogenetic-Based Therapeutic Exploitation of Xanthine Dehydrogenase in Cardiovascular Disease. Antioxidants 2024, 13, 1439.
https://doi.org/10.3390/antiox13121439
AMA Style
Massimo G, Dyson N, Olotu F, Khambata RS, Ahluwalia A.
Potential Opportunities for Pharmacogenetic-Based Therapeutic Exploitation of Xanthine Dehydrogenase in Cardiovascular Disease. Antioxidants. 2024; 13(12):1439.
https://doi.org/10.3390/antiox13121439
Chicago/Turabian Style
Massimo, Gianmichele, Nicki Dyson, Fisayo Olotu, Rayomand S. Khambata, and Amrita Ahluwalia.
2024. "Potential Opportunities for Pharmacogenetic-Based Therapeutic Exploitation of Xanthine Dehydrogenase in Cardiovascular Disease" Antioxidants 13, no. 12: 1439.
https://doi.org/10.3390/antiox13121439
APA Style
Massimo, G., Dyson, N., Olotu, F., Khambata, R. S., & Ahluwalia, A.
(2024). Potential Opportunities for Pharmacogenetic-Based Therapeutic Exploitation of Xanthine Dehydrogenase in Cardiovascular Disease. Antioxidants, 13(12), 1439.
https://doi.org/10.3390/antiox13121439